Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for ImprimisRx

    Client Virtual Booth

    IMPRIMISRX

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    ImprimisRx
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1705 Route 46 W, Suite 4 Ledgewood, NJ 07852
    Telephone
    Telephone
    858.264.2082
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.imprimisrx.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    $1 Daraprim? ImprimisRx facility in New Jersey hit with FDA warning letter
    $1 Daraprim? ImprimisRx facility in New Jersey hit with FDA warning letter

    https://endpts.com/1-daraprim-fda-sends-another-warning-letter-to-imprimisrx-facility/

    Tyler Patchen ENDPTS
    13 Jun 2023
    Share Share
    ImprimisRx Launches Fortisite Compounded Antibiotic Formulation
    ImprimisRx Launches Fortisite Compounded Antibiotic Formulation

    https://www.businesswire.com/news/home/20220929005297/en

    BUSINESSWIRE
    29 Sep 2022
    Share Share
    FDA slaps ImprimisRx with a warning letter over sponsored articles
    FDA slaps ImprimisRx with a warning letter over sponsored articles

    https://endpts.com/fda-slaps-imprimisrx-with-a-warning-letter-over-sponsored-articles-in-medical-journals/

    Beth Snyder Bulik ENDPTS
    20 Jul 2022
    Share Share
    Imprimis Rx LLC Receives FDA Warning Letter
    Imprimis Rx LLC Receives FDA Warning Letter

    https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/imprimis-rx-llc-627802-06302022

    FDA
    20 Jul 2022
    Share Share
    Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops
    Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops

    https://www.businesswire.com/news/home/20211220005121/en

    BUSINESSWIRE
    20 Dec 2021
    Share Share
    FDA Issues Form 483 to Imprimis NJOF, -LLC
    FDA Issues Form 483 to Imprimis NJOF, -LLC

    https://www.fda.gov/media/151431/download

    FDA
    13 Aug 2021
    Share Share
    Harrow Health Announces Second Quarter 2021 Financial Results
    Harrow Health Announces Second Quarter 2021 Financial Results

    https://www.businesswire.com/news/home/20210810005917/en

    BUSINESSWIRE
    10 Aug 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search